Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection

References

• BensonAB3rdVenookAPBekaii-SaabTNational Comprehensive Cancer NetworkColon cancer, version 3.2014J Natl Compr Canc Netw20141271028105924994923
   PubMed Web of Science ®Google Scholar
• LabiancaRNordlingerBBerettaGDESMO Guidelines Working GroupEarly colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi64vi7224078664
   PubMed Web of Science ®Google Scholar
• HallerDGTaberneroJMarounJCapecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancerJ Clin Oncol201129111465147121383294
   PubMed Web of Science ®Google Scholar
• YothersGO’ConnellMJAllegraCJOxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analysesJ Clin Oncol201129283768377421859995
   PubMed Web of Science ®Google Scholar
• AndréTBoniCNavarroMImproved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trialJ Clin Oncol200927193109311619451431
   PubMed Web of Science ®Google Scholar
• HallerDGCatalanoPJMacdonaldJSPhase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089J Clin Oncol200523348671867816314627
   PubMed Web of Science ®Google Scholar
• MurphyCCHarlanLCWarrenJLGeigerAMRace and insurance differences in the receipt of adjuvant chemotherapy among patients with stage III colon cancerJ Clin Oncol201533232530253626150445
   PubMed Web of Science ®Google Scholar
• StotzMPichlerMAbsengerGThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerBr J Cancer2014110243544024357796
   PubMed Web of Science ®Google Scholar
• van ErningFNCreemersGJDe HinghIHLoosveldOJGoeySHLemmensVEReduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or olderAnn Oncol201324112839284423933560
   PubMed Web of Science ®Google Scholar
• BufillJAColorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor locationAnn Intern Med1990113107797882240880
   PubMed Web of Science ®Google Scholar
• YamauchiMLochheadPMorikawaTColorectal cancer: a tale of two sides or a continuum?Gut201261679479722490520
   PubMed Web of Science ®Google Scholar
• SiegelRLMillerKDFedewaSAColorectal cancer statistics, 2017CA Cancer J Clin201767317719328248415
   PubMed Web of Science ®Google Scholar
• BenedixFKubeRMeyerFSchmidtUGastingerILippertHColon/Rectum Carcinomas (Primary Tumor) Study GroupComparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survivalDis Colon Rectum2010531576420010352
   PubMed Web of Science ®Google Scholar
• YamauchiMMorikawaTKuchibaAAssessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumGut201261684785422427238
   PubMed Web of Science ®Google Scholar
• SuttieSAShaikhIMullenRAminAIDanielTYalamarthiSOutcome of right- and left-sided colonic and rectal cancer following surgical resectionColorectal Dis201113888488920594201
   PubMed Web of Science ®Google Scholar
• YahagiMOkabayashiKHasegawaHTsurutaMKitagawaYThe worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysisJ Gastrointest Surg201620364865526573851
   PubMed Web of Science ®Google Scholar
• SinicropeFAMahoneyMRSmyrkTCPrognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyJ Clin Oncol201331293664367224019539
   PubMed Web of Science ®Google Scholar
• BlonsHEmileJFLe MalicotKPETACC-8 Study InvestigatorsPrognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial datasetAnn Oncol201425122378238525294886
   PubMed Web of Science ®Google Scholar
• WangFBaiLLiuTSRight-sided colon cancer and left-sided colorectal cancers respond differently to cetuximabChin J Cancer201534938439326111811
   PubMedGoogle Scholar
• WeissJSchumacherJAllenGOAdjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare dataAnn Surg Oncol20142161781179124643898
   PubMed Web of Science ®Google Scholar
• HuangCWTsaiHLHuangMYDifferent clinicopathologic features and favorable outcomes of patients with stage III left-sided colon cancerWorld J Surg Oncol20151325726311139
   PubMed Web of Science ®Google Scholar
• ZhangYMaJZhangSA prognostic analysis of 895 cases of stage III colon cancer in different colon subsitesInt J Colorectal Dis20153091173118326054387
   PubMed Web of Science ®Google Scholar
• ChauINormanARCunninghamDA randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerAnn Oncol200516454955715695501
   PubMed Web of Science ®Google Scholar
• NawaTKatoJKawamotoHDifferences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histologyJ Gastroenterol Hepatol200823341842317532785
   PubMed Web of Science ®Google Scholar
• TentesAAKorakianitisOSKakolyrisSDifferences between right- and left-sided colon carcinomasJ BUON201015228528920658723
   PubMed Web of Science ®Google Scholar
• SnaebjornssonPJonassonLJonssonTMöllerPHTheodorsAJonassonJGColon cancer in Iceland--a nationwide comparative study on various pathology parameters with respect to right and left tumor location and patients ageInt J Cancer2010127112645265320162576
   PubMed Web of Science ®Google Scholar
• FrankoJShiQMeyersJPAnalysis and Research in Cancers of the Digestive System (ARCAD) GroupPrognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) databaseLancet Oncol201617121709171927743922
   PubMed Web of Science ®Google Scholar
• PhippsAILimburgPJBaronJAAssociation between molecular subtypes of colorectal cancer and patient survivalGastroenterology201514817787.e225280443
   PubMed Web of Science ®Google Scholar
• SinicropeFAShiQSmyrkTCMolecular markers identify subtypes of stage III colon cancer associated with patient outcomesGastroenterology20151481889925305506
   PubMed Web of Science ®Google Scholar
• ShenHYangJHuangQDifferent treatment strategies and molecular features between right-sided and left-sided colon cancersWorld J Gastroenterol201521216470647826074686
   PubMed Web of Science ®Google Scholar
• LeeGHMalietzisGAskariABernardoDAl-HassiHOClarkSKIs right-sided colon cancer different to left-sided colorectal cancer? - a systematic reviewEur J Surg Oncol201541330030825468456
   PubMed Web of Science ®Google Scholar
• ShahMARenfroLAAllegraCJImpact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: analysis from modern-era adjuvant studies in the adjuvant colon cancer end points (ACCENT) databaseJ Clin Oncol201634884385326811529
   PubMed Web of Science ®Google Scholar